Cargando…

Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels

IMPORTANCE: Financial incentives shared between physicians and patients were shown to significantly reduce low-density lipoprotein cholesterol (LDL-C) levels in a randomized clinical trial, but it is not known whether these health benefits are worth the added incentive and utilization costs required...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandya, Ankur, Asch, David A., Volpp, Kevin G., Sy, Stephen, Troxel, Andrea B., Zhu, Jingsan, Weinstein, Milton C., Rosenthal, Meredith B., Gaziano, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324619/ https://www.ncbi.nlm.nih.gov/pubmed/30646152 http://dx.doi.org/10.1001/jamanetworkopen.2018.2008

Ejemplares similares

The association of financial incentives for low density lipoprotein cholesterol reduction with patient activation and motivation
por: Liu, Tianyu, et al.
Publicado: (2019)

Modeling lottery incentives for daily adherence
por: Humphrey, Colman H., et al.
Publicado: (2019)

Effect of Escalating Financial Incentive Rewards on Maintenance of Weight Loss: A Randomized Clinical Trial
por: Yancy, William S., et al.
Publicado: (2019)

A test of financial incentives to improve warfarin adherence
por: Volpp, Kevin G, et al.
Publicado: (2008)

Financial incentive strategies for maintenance of weight loss: results from an internet-based randomized controlled trial
por: Yancy Jr., William S., et al.
Publicado: (2018)

Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial
por: Reese, Peter P., et al.
Publicado: (2021)

Effect of Financial Incentives and Environmental Strategies on Weight Loss in the Healthy Weigh Study: A Randomized Clinical Trial
por: Glanz, Karen, et al.
Publicado: (2021)

Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial
por: Barankay, Iwan, et al.
Publicado: (2020)

Use of financial incentives and text message feedback to increase healthy food purchases in a grocery store cash back program: a randomized controlled trial
por: Gopalan, Anjali, et al.
Publicado: (2019)

A Comparative Assessment of Non-Laboratory-Based versus Commonly Used Laboratory-Based Cardiovascular Disease Risk Scores in the NHANES III Population
por: Pandya, Ankur, et al.
Publicado: (2011)

Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial
por: Mehta, Shivan J., et al.
Publicado: (2019)

Qualitative Analysis of a Remote Monitoring Intervention for Managing Heart Failure
por: Klaiman, Tamar, et al.
Publicado: (2023)

Qualitative analysis of a remote monitoring intervention for managing heart failure
por: Klaiman, Tamar, et al.
Publicado: (2023)

Association between statewide financial incentive programs and COVID-19 vaccination rates
por: Thirumurthy, Harsha, et al.
Publicado: (2022)

Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study
por: Navathe, Amol S., et al.
Publicado: (2019)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Physician Compensation Arrangements and Financial Performance Incentives in US Health Systems
por: Reid, Rachel O., et al.
Publicado: (2022)

Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study
por: Lee, Yujin, et al.
Publicado: (2019)

Triglycerides, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol in rats exposed to premium motor spirit fumes
por: Aberare, Ogbevire L., et al.
Publicado: (2011)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Association of Medicaid Healthy Behavior Incentive Programs With Smoking Cessation, Weight Loss, and Annual Preventive Health Visits
por: Huf, Sarah W., et al.
Publicado: (2018)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
por: Asch, David A., et al.
Publicado: (2022)

High-density lipoprotein cholesterol: How High
por: Rajagopal, G., et al.
Publicado: (2012)

The Role of High-Density Lipoprotein Cholesterol in 2022
por: Sirtori, Cesare R., et al.
Publicado: (2022)

Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
por: You, Jiayin, et al.
Publicado: (2020)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
por: Chu, Shou-Yu, et al.
Publicado: (2019)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Financial Impact of Incentive Spirometry
por: Eltorai, Adam E. M., et al.
Publicado: (2018)

Children, vaccines, and financial incentives
por: Erdem, Orhan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9v07e0omer3jhq2ur7rt9p57pt